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ABBREVIATIONS 
 
GAHS           -   Glasgow alcoholic hepatitis score 
 mDF             -   modified discriminant function 
MELD           -   Model for end-stage liver disease 
ADH              -    alcohol dehydrogenase 
ALDH            -     aldehyde dehydrogenase 
TNF                -    tumour necrosis factor 
IL                    -      interleukin  
IFN                 -     interferon 
TGF                -     transforming growth factor      
AST                -    aspartate transaminase 
ALT                -     alanine transaminase  
ALP                -      alkaline phosphatase 
GGT               -      gamma glutamyl transpeptidase 
AUDIT           -       alcohol use disorder identification test 
NASH             -      non-alcoholic steatohepatitis 
PT                  -       prothrombin time 
INR                -       international normalized ratio  
 
 
  
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
                                            INTRODUCTION 
HISTORY: 
           Alcohol consumption has been prevalent as early as 10000 B.C.-  Beer 
mugs belonging to the Neolithic period( late stone age ) shows the fact that 
fermentation was intentionally done at that time. These earliest beverages are 
made from berries and honey. 
The detailed process of brewing dates back to 2000 B.C. in ancient Egypt 
at the dawn of civilisation.  In ancient Egypt, alcoholic beverages were 
considered very important. In fact, Egyptians had a god of wine, Osiris and 
Osiris was worshipped in the entire country. They had a belief that Osiris 
invented beer. Beer was brewed and used in home daily. Alcohol was offered to 
gods during religious ceremonies. They clearly had limitations in the amount to 
be consumed and the majority who used it , drunk moderately. 
Ancient Chinese believed alcohol to be a spiritual food. It was used in 
moderation during festivals, religious ceremonies, offering rituals, executions, 
marriage, death, battles and celebration of victories. It was one of the main 
source of income to the treasury.  
               
Greeks had a set of rules for drinking like moderate drinking, diluting 
wine with water and avoiding excess consumption. Except during the Dionysus 
cult- which believed intoxication will bring people close to god, majority of 
Greeks upheld the idea of moderation. But  Macedonians viewed drunkenness 
as a symbol of masculinity.                   when Hebrews were exposed to alcohol 
they started using it widely and it even became a part of their religious 
ceremonies like regular wine drinking outside jewish temples              
Early Romanians used wine in moderation. But later half of their period 
was associated with heavy drinking. In india, alcohol dates back to 3000 B.C – 
2000 B.C, during the period of Indus valley civilisation. A drink called sura 
made from fermented wheat, sugarcane and grapes was drunk by kshatriyas. 
Ayurveda texts shows that beneficial effects of alcohol if used in moderate 
amount and harmful effects if consumed in excess.   
By first century B.C. misuse of alcohol became prevalent and intoxication 
occurred with increased frequency 
 With the rise of Christianity by fourth and fifth century A.D. alcohol was 
considered god’s gift, but excess alcohol consumption leading to drunkenness 
was considered as a sin.  In the medieval period, the first clear evidence of 
alcohol distillation occurred at Greece.  
By 15
th
  and 16
th
 century, germans mastered the art of distillation. Some people 
increased their consumption dramatically because of the belief that distilled 
beverages protected them against black death and plague. 
In the modern period, consumption increased gradually. This is the period 
during which many varieties of alcohol like champagne, rum, gin, ale, etc 
started to emerge. The increased consumption lead to gin epidemic in England 
by 17
th
 century. Hence , legislation was passed to limit the sale of gin which 
curbed the rise in consumption. Alcohol production industry became  lucrative.  
Thus alcohol, which was initially consumed as a part of religious 
ceremonies was later consumed in moderation for pleasure. Then, people started 
consuming alcohol to intoxicating levels. Initially the usage was confined to 
elite people. Later on, with the advent of industrialisation , alcohol production 
increased and it became available to all groups irrespective of their economy. 
This lead to increased consumption of alcohol among widespread groups of 
People and the alcohol related diseases started to emerge.  
  
PRESENT SCENARIO IN INDIA : 
Alcohol is the most frequently used drug worldwide and is considered a 
socially acceptable hepatotoxin.  
*About 30 – 35 % of adult males and 5% adult females consume alcohol. The 
male: female ratio was 6 : 1  
 *The average age of initiating alcohol is 17 years. in 1980, this was at 28 years. 
The consumption starts in social circles on experimental basis and then becomes 
addictive. 
* The chances of addiction are increased when drinking was started at a 
younger age.  
* the incidence is high in age group of 41 – 50 years  and people with lower 
education status 
*The average duration of consumption is more than 10 years. the amount drunk  
increases with age. 
* the legal age for drinking varies between 18 to 25 depending on the state 
 
*IMFL( Indian made foreign liquor ) and Beer is the most preferred among 
youngsters, brandy and rum among people in rural regions 
*usage is high in goa, north-eastern and southern states  
*revenue related to taxation from liquor industry is one of the major sources of 
income to the government 
*only half of the consumption is documented. 
*half of the drinkers come under the category of hazardous drinking 
* the documentation of hazardous consequences of alcohol was not done 
Properly 
* alcoholics have higher morbidity, hospitalisation and mortality 
* alcohol is involved in 20 -30 % of road traffic accidents 
* increased association with HIV and other sexually transmitted diseases 
*it is a co-morbid factor for psychiatric illnesses 
 
 
 
* Higher Cardiovascular morbidity among alcoholics  
*violence and abuse of women and children are linked with alcoholism 
*increasing crime rates have been linked with alcohol. 
*prohibition of alcohol didn’t had an effect on consumption. Instead, smuggling 
and illegal consumption increased 
* alcoholics  feel guilty because of their drinking and this prevents them from 
seeking medical care 
*alcoholism leads to the loss of economy by two ways – one, due to the money 
spent on alcohol and two, the resources spent on managing alcohol related 
injuries, accidents and medical illnesses 
 
The emerging trends are 
- social drinking  was considered as a part of life style  
- Initiation at earlier, younger age 
- Increasing consumption among females 
 
- Higher  consumption among sub-urban and rural areas 
- Preference for drinks with high alcohol content  
    The need of the hour is a scientific and a rational alcohol control policy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ALCOHOLIC LIVER DISEASE: 
           Alcoholic liver disease (ALD) includes a wide range of injury,  from  
reversible Steatohepatitis  to irreversible cirrhosis.  Alcohol is a common cause 
of liver disease worldwide.  Pathologically, the varied manifestations of the 
disease are shown below: 
   
 
Among these, alcoholic hepatitis is a very important entity because , 
severe alcoholic hepatitis is associated with very high  short-term mortality 
rates. So  far,  the severity is identified by calculating modified Discriminant 
function.     m DF  greater than or equal to 32 is considered severe and treated 
with steroids or pentoxifylline . Thus it is important for an accurate scoring 
system to identify and treat the severe patients. 
The mDF includes only PT and bilirubin in calculating the severity of 
Alcoholic hepatitis. But the presence of renal involvement  indicates severe 
disease with a short-term mortality rate of 75%
[1]
.  
Also, in alcoholic hepatitis the inflammatory mechanisms  play an 
important role   in pathogenesis, which is why the steroids are being used as 
treatment. The importance of  renal involvement or inflammation in 
determining the severity of  disease  is not estimated in mDF score.         
Hence there is a need for a new scoring system which can involve the 
renal function and inflammation. The Glasgow Alcoholic Hepatitis Score 
involves age, White cell count, urea, PT and bilirubin in calculating the 
prognosis  of alcoholic hepatitis and identifying the patients in need  of drug 
therapy. Since it involves markers for renal dysfunction and inflammation , it 
can be more accurate than  mDF . 
Hence, it sounds worthy for me to take up this comparative study of 
prediction of 1 month mortality in alcoholic hepatitis by mDF and GAHS 
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AIMS AND OBJECTIVES 
1]  To estimate the 1 month mortality in alcoholic hepatitis by using  mDF 
and GAHS Score 
2]  To assess the accuracy of each scoring system in predicting 1 month 
Mortality. 
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REVIEW OF LITERATURE 
PATHOGENESIS OF ALCOHOL INDUCED LIVER INJURY 
ALCOHOL METABOLISM IN LIVER: 
The major organ for alcohol metabolism is liver. Ethanol is metabolised 
by  three major enzyme systems: 
1]  alcohol dehydrogenase[ADH] 
         2]  cytochrome P450 isoenzymes, mainly cytochrome P450 2E1  
         3]  Catalase.  
         Of these, the main enzyme system involved in alcohol metabolism is 
ALCOHOL DEHYDROGENASE[ADH], located in the cells of the liver
[2]
. It 
metabolises 80-85% of ethanol.The Cytochrome P450  isoenzymes, 
predominantly CYP2E1 is situated  in the smooth Endoplasmic Reticulum as a 
part of  microsomal  ethanol-oxidising system. This system metabolises ethanol 
at higher blood concentrations[greater than 10 Mm] and contributes to 10-15% 
of ethanol metabolism
[3]
. The catalase enzyme  present in peroxisomes is  
of minor importance, because it metabolises less than 5% of ethanol in the liver. 
Ethanol is converted to acetaldehyde by the above three systems. 
Acetaldehyde is converted to acetate by aldehyde dehydrogenase[ALDH].   
Ethanol 
     ADH
                    acetaldehyde            
ALDH
           acetate  
      
Polymorphisms in ADH results in different elimination rates in different 
individuals. Various active  isoforms like  ADH2 and ADH3  results in rapid 
metabolism of alcohol. These individuals have lower tolerance of alcohol, but 
they produce more acetaldehyde rapidly resulting in increased liver injury
[3].
  
                                     
The major isoenzyme in aldehyde dehydrogenase is ALD H2. It is the 
predominant  metabolism of  aldehyde oxidation .Inactive ALD H2 is found in 
50% east Asians resulting in impaired acetaldehyde metabolism causing 
flushing and tachycardia after alcohol consumption –“ oriental flush syndrome”. 
  
METABOLIC ABNORMALITIES: 
The metabolic abnormalities that arise in alcoholic liver disease includes 
several mechanisms: 
1] Acetaldehyde – it is a highly reactive and toxic compound. It forms 
adducts with proteins and small molecules , thus interfering with normal 
biologic processes. These modified proteins induces  host’s immune system and 
results in auto-immune like mechanisms. This type of injury is specific  to 
alcohol. 
           2] Shift in ratio of NADH to NAD+ to a more reduced state. This 
inhibits lactate to pyruvate conversion and fatty acid oxidation, resulting in 
impaired carbohydrate and lipid metabolism. 
          3] Oxidative stress – CYP2E1 system leaks electrons to initiate oxidative 
Stress. Also the increased NADH/NAD+ ratio favours superoxide generation. 
  
IMMUNE   AND  INFLAMMATORY MECHANISMS: 
1] DYSREGULATED CYTOKINE PRODUCTION AND KUPFFER 
CELL ACTIVATION:  
In alcoholic liver disease, the increased intestinal permeability causes 
frequent endotoxemia. This intestine derived LPS activates reticuloendothelial 
cells of the liver, thereby stimulating cytokines. Also the reactive oxygen 
species stimulates proinflammatory cytokine production. The production of 
immunomodulatory  cytokines which  counter-act these detrimental effects  are 
decreased.  
TNF metabolism is dysregulated. TNF is produced  in significantly 
increased amounts because of the gut-derived endotoxin stimulation.  serum 
TNF concentrations  show a strong correlation with disease severity and risk of 
mortality. The levels of pro-inflammatory cytokines in Serum are increased to 
alarming levels  and the levels often correlate with  acute-phase reactants, 
reduced hepatic  function, and poor  outcomes. This enhanced cytokine 
response to a physiologic stimulus such as LPS is termed priming.  
Hepatocytes normally are resistant to TNF killing. However, hepatocytes 
in alcoholic hepatitis are sensitized to TNF killing. Mechanisms for this 
sensitization include mitochondrial depletion of glutathione, accumulation of 
SAH, and inhibition of proteosomes, among others. Thus both  
reticuloendothelial cells are primed and hepatocytes are sensitised, resulting in 
liver damage 
2]   IMMUNE RESPONSE TO ALTERED HEPATIC PROTEINS: 
Alcoholics develop  immune or autoimmune response by autoantibodies 
against phospholipids, heat shock proteins and other antigens
[1]
. They also 
develop immune responses against neoantigens generated from the interactions 
of metabolites of alcohol (e.g., acetaldehyde or hydroxyethyl radicals) with liver 
proteins. In fact, alcoholic hepatitis may persist histologically for several 
months after thanol exposure has been stopped. 
  
 Role of Cytokines  
Cytokine Mechanism  
Pro–inflammatory cytokines 
 IL-1 Stimulates inflammation, results in fever 
IL–6 Causes B lymphocyte proliferation and antibody production 
TNF–α Stimulates macrophages. Triggers apoptosis and necrosis 
TGF–β Promotes collagen synthesis 
Immunoregulatory cytokines 
IL–10 
Prevents mitosis in reticuloendothelial cells. it is decreased in 
alcoholic hepatitis  
Chemokines 
IL–8  Attracts PMNs. 
 
 
 
 
 
 
 
 
Immunological mechanisms in alcohol induced hepatic injury 
 
  
  
DIAGNOSIS OF ALCOHOL ABUSE: 
 Alcohol abuse  is defined in an individual who has frequent problems in 
social, legal, occupational and interpersonal relationships. It can be diagnosed if 
an individual is consuming alcohol in dangerous  situations like driving. It can 
be defined only when there is no alcohol dependence. 
 The diagnosis of alcohol abuse can be done using AUDIT-C and the 
CAGE questionnaire. The denial of patients and inadequate questioning by 
physicians results in underdiagnosis of patients. The CAGE questionnaire 
dramatically improves  the recognition of patients with problem drinking in 
primary care clinic. 
 
   When two of the four questions are answered yes, it has 90% specificity 
in identifying problem drinking.  The problems in CAGE are its lesser 
reliability in women and pregnancy.                         
The TWEAK questionnaire helps to identify at risk pregnant drinkers 
  The Michigan Alcoholism Screening Test ( MAST ) is a 25 item  
questionnaire used to identify abuse. But it is cumbersome and could not be 
used easily.  
 Alcohol Use Disorders Identification Test (AUDIT) is a 10-item 
questionnaire  designed by the WHO  for  screening  of problem drinking . The  
first three questions are used to assess the quantity, frequency, and peak 
intensity of drinking and the next Seven  questions deal with issues in the past 
year. The AUDIT is scored by means of summation of the weights associated 
with the response selected for each item.  
 A total ≥  8 for men up to age 60, or  ≥ 7 for  women, adolescents, or 
men over age 60 is considered a positive screening test.. Any value greater than 
this suggests alcohol abuse; higher values increase the reliability of the 
diagnosis of alcohol abuse. The AUDIT score has been considered a better 
predictor of social problems than   laboratory markers     
   AUDIT  can be finished in 2 to 4 minutes. At the end of first question if 
the patient says no drinking in the previous year we can straightaway go to the 
ninth question. Likewise if the patient has a sum score of 0 on second and third 
question, we can straightaway go to the ninth question. In this way AUDIT  can 
be shortened.  The advantages of AUDIT are: 
- It  identifies  drinkers who are at risk of dependency 
- It quantitates the amount consumed 
- It inculcates short-term as well as long-term drinking patterns 
- Takes less time  
- Can be done in an easier way 
- Accuracy is more 
- Easily computed and compared for epidemiological purposes 
The ability to predict the existence of other alcohol-related illnesses on 
the basis of AUDIT results was similar to that with laboratory tests.   
Laboratory tests are needed to confirm the diagnosis. Clinical 
differentiation of  the stages of ALD is difficult at times, and no clinical sign 
definitively say that alcohol as the cause of liver disease. 
  
 
           Each question will be given points ranging from 0 to 4. A total ≥ 8 for 
men up to age 60, or ≥ 7  for women, adolescents, or men over age 60 is 
considered a positive screening test. 
Management based on AUDIT : 
AUDIT SCORE Intervention 
0-7 Health education 
8-15 Advice  
16-19 Advice + counselling + continuous 
monitoring 
20-40 Referral to specialist  
                    
 AUDIT has been designed to cover all the problems related to drinking: 
- If a drinker has a score of ≥ 1 on   2nd or  3rd   question, it implies 
hazardous consumption 
- A score above 0 on questions 4 to 6 shows alcohol dependence 
- Scores above 0 on 7th to 10th questions denotes that the patient is currently 
experiencing the problems related to alcoholism  
 
Blood or breath alcohol measurements are the most sensitive and  specific 
indicators of recent alcohol abuse, particularly for binge drinkers. The  major 
limitation of these tests is the short half-life of ethanol in blood, urine, and 
breath.              
Biomarkers of alcohol abuse that are detectable over longer periods can 
be used. The most specific of these biomarkers is carbohydrate-deficient 
transferrin (CDT). CDT levels increase in serum with ingestion of 50 to 80 
g/day of ethanol for two to three weeks and decline gradually during abstinence, 
with a half-life of approximately 15 days. The problem with CDT is it has a 
sensitivity of  only 35% to 40%  if  consumption is  100 g of ethanol daily. Also 
it is  influenced by various factors like age, sex, body mass index, etc. Hence it 
is not  used in clinical practice. It is a FDA approved test. Other parameters 
include MCV, GGTP levels and ratio of mitochondrial AST to total AST. 
  
Alcoholic hepatitis: 
 Alcoholic hepatitis is a clinical syndrome of icterus and hepatic 
dysfunction that usually manifests following  continuous excessive  alcohol 
intake[average of 100 g /day ]. The usual  age at which the disease presents  is 
40 to 60 years, but can vary from 20 to 80 years. The cardinal sign is rapid  
onset of jaundice. Typically, the liver is enlarged and tender
[6]
. The importance 
of alcoholic hepatitis lies in its potential reversibility. 
 Documentation of chronic and significant alcohol abuse is important. 
Minimum of 80 g/day for 5 years is typical. Patient may have stopped alcohol 
consumption several weeks before, but  Clinical presentation after 3 months of 
abstinence should raise  doubts about the diagnosis of alcoholic hepatitis and 
these patients should be evaluated for other causes of liver damage such as 
cirrhosis and sepsis
[8]
.  
  
HISTOLOGY: 
Ballooning:                                 
The hepatocytes becomes swollen due to accumulation of fat, proteins 
and water. Later they become necrosed. 
Mallory bodies: 
Accumulation of intermediate filaments are seen as eosinophilic 
cytoplasmic inclusions. They are called Mallory bodies. they are non-specific.  
They can be present in Wilsons disease, primary biliary cirrhosis, chronic 
Cholestasis and liver malignancy. 
Neutrophil infiltration: 
Neutrophils surround the degenerating hepatocytes. They have  
predilection to involve hepatocytes with Mallory bodies. lymphocytes and 
macrophages are also recruited. 
  
Fibrosis:  
Sinusoidal and perivenular fibrosis occurs.it is predominantly found in 
zone 3. Periportal fibrosis will be the dominant picture in repeated bouts of 
heavy drinking.  
Cholestasis : 
Mortality is increased in marked cholestasis. 
The histology varies depending on the severity of the disease. These 
histological changes can be seen in NASH too. Hence, in a patient with 
adequate alcohol intake history and laboratory features, histology is the gold 
standard for the diagnosis of alcoholic hepatitis 
 
  
Picture showing ballooning of hepatocytes, micro and macrovesicular steatosis 
and Mallory hyalin
 
DIAGNOSIS  IN CLINICAL PRACTICE: 
However there are problems in clinical setting in obtaining biopsy. If the 
patient has ascites and/or coagulopathy, percutaneous liver biopsy cannot be 
performed. Still transjugular biopsy can be done, but this needs expertise which 
may not be immediately available. Even if biopsy is done, if it is relied upon for 
diagnosis, delay in management will occur. 
Hence in practice, the disease is suspected when icterus  and other 
symptoms  and signs of decompensation like ascites happens to an individual 
with excess ethanol intake
[4]
 . however in the study conducted by HISLOP et al 
in Scotland and north east England biopsy  done in the patients showed that 
only 65% of biopsy proven disease had icterus and 5% had encephalopathy.  
The common presentations in biopsy proven alcoholic hepatitis includes a 
wide range of signs and symptoms like vomiting, hepatomegaly, ascites, 
splenomegaly, encephalopathy, etc 
Clinical diagnosis  has an accuracy of about 80% when compared with 
histology. However,  along with history of chronic excess alcohol 
ingestion,AST  < 500 [or ALT < 300] and exclusion of autoimmune ,chronic 
viral or malignant diseases if serum bilirubin was set at a minimum level of > 
80  µmol/l[4.67 mg/dl] the accuracy becomes 99.2%. in this study too the  
inclusion criteria of serum bilirubin is  > 5  mg/dl to improve the diagnostic 
accuracy. 
Approximately 50-60 % patients will also have co-existing cirrhosis. But 
this doesnot seem to worsen the 28 day and 84 day mortality of patients.  The 
reason for poor prognosis in these patients are pro-inflammatory Processes 
  
CLINICAL FEATURES: 
              It can be divided into 4 types: 
1]  Features specific to existing alcoholic hepatitis- although clinical jaundice 
occurs only in 40-60% of cases , all cases will have hyperbilirubinemia. Other 
features include right upper quadrant pain, fever, tachycardia. Fever can be in 
the range of 100.4 to 104 F.  This fever can be attributed to  alcoholic hepatitis 
only after excluding infections and malignancy. Malnutrition can be present in 
upto 90% patients . severe disease can have hepatic encepahalopathy, renal 
failure,ascites. 
2]  Features due to underlying cirrhosis – this includes spider naevi, palmar 
erythema  
3] Features of associated diseases – like  co-existing infections 
4] Features of alcohol withdrawal – the frequency of alcohol withdrawal is 
inversely proportional to the severity of the disease 
  
Laboratory features: 
Liver function tests: 
Liver enzymes: 
 The usual picture will be an increase in AST and ALT to two-to seven 
fold. Usually   the AST/ALT ratio usually is of little value in differentiating 
various hepatobiliary disorders. One of the exceptions to this is the recognition 
of alcoholic liver disease. If the ALT is less than 300 IU , an AST/ALT ratio 
more than 2 suggests alcoholic liver disease; a ratio greater than 3 is highly 
suggestive of alcoholic liver disease. The increased ratio  shows  the decresed  
ALT  level  in patients with alcoholic liver disease. This is secondary to a 
deficiency of pyridoxal 5′-phosphate . although both AST and ALT needs 
pyridoxal 5’-phosphate, the requirement of ALT is more. The altered AST/ALT 
ratio in serum appears to reflect the altered ratios in the liver. 
 Very high levels suggest complicating paracetamol ingestion.  A Smaller 
dose of paracetamol  can predispose  alcoholics into severe hepatitis. Levels  of 
more than 500 suggests causes other than alcoholic hepatitis.This is because of 
alcohol induced induction of CYP450 in MEOS[microsomal enzyme oxidising 
systems]. This increased MEOS activity causes increased production of toxic 
metabolite of paracetamol, N-acetyl-P-benzoquininemine[NAPQ]. A variant of 
alcoholic hepatitis called alcoholic foamy degeneration can cause AST  to raise 
upto 730 u/l. Despite striking elevations, the AST/ALT ratio remains increased 
and typical of alcoholic liver disease.  
Serum ALP levels will be increased to modest amount of upto three times 
upper limit of normal.  Regarding   the clinical value of GGT, its use lies in 
conferring organ specificity to an elevated value of alkaline phosphatase, 
because GGT activity is not elevated in patients with bone disease. In addition, 
high GGT values are found in patients who take medications such as 
barbiturates or phenytoin  or ingest large quantities of alcohol , even when other 
serum enzyme and bilirubin values are normal. When the elevated GGT value is 
associated with the use of anticonvulsant drugs or alcohol abuse, no correlation 
between serum GGT and alkaline phosphatase values is seen. Aside from its 
value in conferring liver specificity to an elevated alkaline phosphatase  
level and its possible use in identifying that a patient abuses alcohol, GGT 
testing offers no advantage over aminotransferase and alkaline phosphatase 
testing. 
 
Serum albumin: 
The long serum half-life of albumin in serum accounts for its unreliability 
as a marker of hepatic synthetic function in acute liver injury. Serum albumin 
levels less than 3 g/dL in a patient with newly diagnosed hepatitis should raise 
suspicion of a chronic process . Serum albumin is an excellent marker of hepatic 
synthetic function in patients with chronic liver disease and cirrhosis, with the 
exception of patients with cirrhosis and ascites, who may have normal or 
increased albumin production but an increased volume of distribution that 
results in a low serum albumin level. 
 When it is less than 2.5 mg/dl , it indicates severe disease. Serially  
increasing albumin levels shows that the patient is improving. Because of its 
low prognostic value in acute hepatic diseases it is not used in the prognostic 
scoring in alcoholic hepatitis 
 
Serum bilirubin: 
In other diseases total serum bilirubin level is not a sensitive indicator of 
hepatic dysfunction and may not accurately reflect the degree of liver damage. 
Hyperbilirubinemia may not be detected in instances of moderate to severe 
hepatic parenchymal damage or a partially or briefly obstructed common bile 
duct. Few controlled studies have critically assessed the prognostic value of 
magnitude and duration of hyperbilirubinemia in liver disease and have shown 
that In acute alcoholic hepatitis, hyperbilirubinemia correlates with  a poor 
prognosis. Levels > 8 mg/dl indicates severe disease.  
Also in severe disease,  it is  measured 1 week after starting steroids to 
determine the response to treatment. 
 PT/INR: 
Measurement of the prothrombin time in patients with liver disease is 
most useful in cases of acute liver disease. Unlike the serum albumin, the 
prothrombin time allows an assessment of current hepatic synthetic function; 
factor VII has the shortest serum half-life (six hours) of all the clotting factors. 
It also correlates with severity of disease. The prothrombin test is not a sensitive 
index of chronic liver disease because, even in severe cirrhosis, prothrombin 
levels can be normal or the prothrombin time prolonged only slightly. 
  Also it has high prognostic value, particularly for patients with acute 
hepatocellular disease. An abnormal prothrombin time with confirmed 
prolongation more than 5 to 6 seconds above control often precedes by days the 
manifestations of liver failure.  Progressive return of the prothrombin time to 
normal usually precedes or accompanies other evidence of clinical 
improvement. The degree of prolongation of the prothrombin time is a 
prognostic factor for patients with alcoholic steatonecrosis. A prothrombin time 
greater than 4 seconds above control value occurred six times as often in a 
group of patients who died (60%) than in a group who survived (10%). 
  
Complete Blood Count: 
It shows mild anemia(usually macrocytic), platelets in the range  of 
normal to decreased and elevated white cell count. White cell count elevation to 
upto 40,000 are common. PMN > 5500 in the presence of m DF > 32 indicates 
poor prognosis. The presence of leukemoid reaction implies very poor 
prognosis. Since patients present with fever and leukocytosis clinicians will 
always have a concern for sepsis alcoholics , being malnourished are at 
increased risk of infection. Hence a minimum evaluation for fever should 
include chest x ray,  blood culture, paracentesis(if ascites is present), urine 
analysis and culture and specific testing if localised signs of infection are 
present. After ruling out infection, the fever can be attributed to alcoholic 
hepatitis. 
  
RENAL FUNCTION TESTS 
The values of urea and creatinine rises. The  patient can develop 
hepatorenal syndrome. Hepatorenal syndrome development is associated with 1 
month mortality of 75%. These elevations are found to have statistically 
significant correlation with the severity of the disease. Hence the rise of urea 
and creatinine tells about the  Prognosis. 
  
ROLE OF LIVER BIOPSY: 
Liver biopsy is useful but not  necessary  for the diagnosis. It  assumes 
greater importance in the evaluation of patients who continue to have abnormal 
results of liver tests after a period of abstinence of approximately 3 to 4 months. 
It is difficult to identify the prothrombin time at which  needle biopsy of the 
liver are contraindicated because the risk of bleeding has not been well 
correlated with the values of this test. The accepted cut-off value is PT 
prolongation of more than 4 seconds and INR>1.5. 
  
ROLE OF IMAGING: 
 The primary utility lies in identifying  mass lesions like hepatocellular  
carcinoma and analysing the presence of cirrhosis 
 It helps to rule out other diseases which might cause similar biochemical 
profile. 
 If biopsy is planned, baseline imaging is done to evaluate silent mass 
lesions and to understand the  anatomy 
 MRI features which indicates ALD are caudate lobe enlargement and  
decreased regeneration 
 However these differences are never absolute 
 Also sonogram or CT cannot clearly  delineate fatty liver from 
steatohepatitis. 
 
 
 
 
Other investigations : 
                  In the evaluation of patients with symptoms, nonspecific findings 
include elevated urate, lactate, and TGL levels and a decrease in magnesium, 
phosphate, and potassium levels. Polyclonal  hyperglobulinemia and an increase 
in the circulating level of immunoglobulin A (IgA) also occurs with ALD It 
must be reiterated that no specific laboratory test exists that is specific for ALD. 
A recently described tool for the diagnosis of ALD is hepatic phosphorus 
31 magnetic resonance spectroscopy . This study is used to calculate hepatic 
energy metabolism and phospholipid membrane metabolism Lower 
phosphodiesterase to adenosine triphosphate ratios have been reported in 
patients with alcoholic cirrhosis 
Frequent measurement of serum ethanol levels during office visits Can be 
done easily. But this is  often-ignored method of assessing for alcohol use. 
Other laboratory parameters  include β hexosaminidase and urinary 5 hydroxy 
tryptophol levels , which must be subjected to prospective testing at several 
centers  before the validity can be confirmed.  
 
Endoscopy:  
It is used when an alcoholic presents with active upper gastrointestinal 
bleeding.  In the clinical situation of alcohol abuse, upper gastrointestinal 
bleeding may be secondary to a variety of causes that include Mallory-Weiss 
tear, peptic ulcer disease, direct alcohol-induced gastric mucosal erosions and 
injury, portal hypertensive bleeding from varices, and congestive gastropathy 
secondary to cirrhosis. Alcohol abuse also is associated with a direct inhibitory 
effect on hepatic protein synthesis and a decrease in procoagulant factors that 
aggravate the bleeding once it begins. Therefore, endoscopy has both diagnostic 
and therapeutic value in such scenario.  
 
 
 
 
 
 
PROGNOSIS : 
          The prognosis among patients with alcoholic hepatitis can vary 
dramatically. In patients with severe disease, the mortality rate is high, similar 
to  that of  acute fulminant hepatic failure.  Severity can be identified by the 
occurrence of   encephalopathy, significantly prolonged PT, very high serum 
bilirubin level , depression of the serum albumin level, high serum creatinine 
level, and older age.  
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Three models have been shown to analyse short-term prognosis  
1. mDF : 
It is discovered by   Maddrey and Boitnott. It is  calculated as 4.6    PT 
prolongation( Patient’s− control value (seconds) + serum bilirubin (mg/dL). The 
mDF has proved useful for delineating 28 day and 84 day mortality. Evidence  
has proven  that patients with a mDF value of 32 or more experience a worse 
prognosis, with 28 day mortality rates of 35% to 45%.  
By contrast, patients with a  mDF value less than 32 have short-term 
survival rates of 90% to 100%.  
The MELD score (which includes the serum bilirubin level, INR  along 
with  creatinine level) and the Glasgow alcoholic hepatitis score (which 
includes age, WBC count,  urea  level, prothrombin time ratio [ratio of the 
patient's prothrombin time to the control value] along with serum bilirubin 
level) also have been shown to predict survival in patients with severe alcoholic 
hepatitis. Because both the MELD and Glasgow scores include measures of 
renal function, they appear to be more accurate than the mDF in determining the 
prognosis of patients. 
 
Scoring Systems:                        
Discriminant Function =  (4·6 x PT) +Serum Bilirubin (mg/dl) 
Modified Discriminant Function = 4·6 X (PTPATIENT – PTCONTROL) + 
Serum Bilirubin ( mg/dl) 
Prognosis poor if score ≥ 32 
MELD score = 3.78[Ln serum bilirubin (mg/dL)] + 11.2[Ln INR] + 9.57[Ln 
serum creatinine (mg/dL)] + 6.43 
Prognosis poor if score ≥18  
Glasgow Alcoholic Hepatitis Score 
Score 1 2 3 
AGE <50 >50  
WCC(10
9
) <15 >15  
UREA(MMOL/L) < 5 >5  
PT ratio or INR <1.5 1.5 – 2 >2.0 
Bilirubin(µmol/l) <125 125-250 >250 
 
Prognosis poor if  score ≥ 9 
          The disadvantage in MELD score is that 
1) It needs calculators for calculation since it involves logarithms 
2) It includes creatinine as a measure of renal function. Evaluation  of  
creatinine is commonly done  based on jaffe reaction. In diseases 
associated with hyperbilirubinemia, creatinine will be underestimated.  
So the observed value based on jaffe’s method needs correction, which is 
more cumbersome 
GAHS is more easy to calculate and it uses urea as a measure of renal 
function  
ABIC score : 
(age x 0.1) + (serum bilirubin x 0.08) + (serum creatinine x 0.3) + (INR x 
0.8) 
Score ≥ 9 indicates poor prognosis 
 
 
 
Lille score :  
          It is used to identify patients who donot respond to corticosteroids at the 
end of one week, so that alternate therapies can be considered.  It  combines  6  
variables: 
      1.age 
2. renal insufficiency 
3.  Albumin 
4.  prothrombin time 
5.  bilirubin, and 
6. evolution of bilirubin at day 7.    
All these variables have been studied and found that each is individually 
associated with altering the prognosis.     A score > 0.45 signifies steroid failure 
and steroids should be stopped. These patients have a survival of 25 %. 
The disadvantage is that it necessitates the need of calculators       to 
calculate  
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                     MATERIALS AND METHODS 
STUDY DESIGN      : OBSERVATIONAL STUDY 
STUDY PLACE       : Department of  general medicine and 
medical gastroenterology  
Government Stanley Hospital, Chennai -1.  
STUDY PERIOD : 6 months (march 2012 – august 2012) 
STUDY 
POPULATION 
: Patients admitted with alcoholic hepatitis 
SAMPLE SIZE : 50 patients 
SAMPLING : Simple random sampling 
 
  
Inclusion criteria:      
• Pt. with hepatitis with alcohol consumption of > 80 g/day for 10 years. 
• Bilirubin > 80 micromol/l 
• AST < 500 u/l 
Exclusion criteria:  
• Alcohol intake < 20 g/day 
• Pt. on amiodarone 
• Hbs Ag positive 
• Anti-HCV positive 
• GI  bleeders 
• Autoimmune liver diseases 
• Liver malignancy 
• Inpatient stay of less than 48 hours  
  
  After getting approval from the institutional ethical committee, the study 
was started. All the individuals in this study were given information form and 
consent form. After signing the informed consent form they were enrolled in 
this study. 
HOW THE STUDY WAS CONDUCTED 
           Patients admitted with alcoholic hepatitis were included in the study after 
applying the inclusion and exclusion criteria. They were subjected to thorough  
history , clinical examination , biochemical investigations, ultrasonogram of the 
abdomen. They were followed up after one month of their present admission. 
Assessment panel includes- 
 History , with specific focus on alcohol intake- amount,  type and 
duration and with AUDIT score ≥ 8 in males and ≥ 7 in females and 
elderly males 
 Age  
 Biochemical investigations : 
      -  white  cell count 
        - serum urea 
        - serum bilirubin 
       - PT and INR 
       - SGOT and SGPT 
 Ultrasonogram   of abdomen done to exclude cirrhosis and  malignancy 
Results were duely collected and analysed 
The patients were followed up for one month and the mortality is 
assessed   mDF  and GAHS were calculated. Downloadable calculators 
were used for  calculation. These  calculators requires only variables to be 
submitted. 
 
Modified Discriminant Function :  
4·6 (PTPATIENT – PTCONTROL)   +Serum Bilirubin (mg/dl) 
  
Glasgow Alcoholic Hepatitis Score 
Score 1 2 3 
AGE <50 >50  
WCC(10
9
) <15 >15  
UREA(MMOL/L) < 5 >5  
PT ratio or INR <1.5 1.5 – 2 >2.0 
Bilirubin(µmol/l) <125 125-250 >250 
 
The patients with m DF ≥ 32 were given prednisolone for four weeks and 
then tapered over next four weeks. If the patient had contraindications to 
steroids, pentoxifylline is given. The patients were followed for one month and 
the mortality is observed. 
 Sensitivity, specificity and accuracy of mDF  and GAHS  in calculating 1 
month mortality were calculated. The results were analysed. P-value of  0.05 is 
considered statistically significant.         
 
  
  
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
RESULTS 
This study included 50 patients diagnosed with alcoholic hepatitis 
admitted in department of general medicine and medical gastroenterology, 
government Stanley hospital. The one month mortality prediction by modified 
discriminant function and GAHS score is calculated and compared with 
observed one month mortality. The results were tabulated and analysed as 
follows: 
Table 1 . AGE DISTRIBUTION 
AGE GROUP [years] Number Percentage 
21-30 7 14 
31-40 18 36 
41-50 16 32 
Above 51 9 18 
 
 
 
 
 
  
Table 2. Sex Distribution 
SEX NUMBER 
Male 49 
Female 1 
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> 51
 Majority in our study group are males 
 
 
 
 
 
 
 
 
 
SEX DISTRIBUTION 
MALE
FEMALE
Trend Chi-square to compare the proportions 
Age group 
(years) 
1 month Mortality 
Total 
P-Value Survived Died 
N % N % N % 
21 - 30 7 100.0 0 0.0 7 100.0 
0.005 
31 - 40 14 77.8 4 22.2 18 100.0 
41 - 50 11 68.8 5 31.3 16 100.0 
>51 3 33.3 6 66.7 9 100.0 
Total 35 70.0 15 30.0 50 100.0 
 
         This table shows that as age increases, the mortality increases too. 
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Age group (years) 
Age group and One month mortality Survive
d
Independent samples t-Test to compare mean values between Variables 
AGE 
Variable 
1 month 
Mortality 
N Mean 
Std. 
Deviation 
P-Value 
Age (years) 
Survived 35 38.23 7.99 
0.002 
Died 15 46.80 9.33 
 
      This table shows that patients who survived had a mean age of 38.23 
whereas patients who died at the end of 1 month had a mean age of 46.8. This 
difference is significant as suggested by a p-value of 0.002 
 
 
WHITE CELL COUNT 
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38.23 
46.8 
MEAN AGE(in years) 
MEAN AGE
 Variable 
1 month 
Mortality 
N Mean 
Std. 
Deviation 
P-Value 
WCC 
Survived 35 8917.1 3324.5 
<0.001 
Died 15 15913.3 4652.6 
 
 
           Patients who died at the end of 1 month had significantly raised white 
cell count( mean of 15913) with a p-value of < 0.001 indicating the importance 
of white cell count in indicating the prognosis of alcoholic hepatitis. 
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SERUM UREA  
Variable 
1 month 
Mortality 
N Mean 
Std. 
Deviation 
P-Value 
Urea 
Survived 35 31.74 8.98 
0.014 
Died 15 38.63 8.15 
 
  Patients who died at the end of 1 month had significant rise in urea 
compared to those survived(p- 0.014), indicating renal involvement  altering the 
prognosis of alcoholic hepatitis 
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SERUM BILIRUBIN 
Variable 
1 month 
Mortality 
N Mean Std. Deviation P-Value 
Total bilirubin 
Survived 35 8.81 2.46 
0.007 
Died 15 13.39 5.57 
 
The average value of serum  bilirubin in patients who died was 
13.3,compared the value of 8.81 in those who survived ( p- value  = 0.007 ) 
indicating it’s value in assessing the prognosis 
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PROTHROMBIN TIME: 
Variable 
1 month 
Mortality 
N Mean Std. Deviation P-Value 
PT 
Survived 35 17.17 2.07 
0.073 
Died 15 18.33 2.02 
 
            In our study, the prothrombin time among the patients who died was 
raised Compared to those who survived, but this rise was not statistically 
significant(p- value  -  0.073). 
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Comparison of  mDF  and GAHS in patients who died at 1 month :    
m DF and GAHS score 
Died 
N % 
m DF<32.0 & GAHS<9.0 1 6.7 
m DF<32.0 & GAHS≥9.0 2 13.3 
m DF≥32.0 & GAHS<9.0 0 0.0 
m DF≥32.0 & GAHS≥9.0 12 80.0 
Total 15 100.0 
 
  Of the 15 patients who died , 12 were detected as having severe  disease  
by  both mDF and GAHS. But 2 patients who had  mDF < 32 and  GAHS ≥9 
died. These patients if identified as severe , could have benefitted with steroids 
or pentoxifylline.  1 patient who had  both  mDF  < 32 and GAHS < 9 died and 
both scores failed to identify the severity.   GAHS identifies severity in all 
patients identified by mDF ≥ 32, apart from identifying severe disease in 
patients with mDF < 32. The only patient where GAHS failed, mDF too failed 
to identify the severity . 
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m DF & GAHS score cut off points and One 
Month Mortality 
Kappa Statistics to measure the Agreement between the two scoring 
procedures 
 
m DF Score 
Total 
≥  32.0 < 32.0 
GAHS Score 
≥ 9 14 2 16 
< 9 9 25 34 
Total 23 27 50 
 
Measure of Agreement Value P-Value. 
Kappa 0.547 <0.001 
 
 Kappa value of 0.547 shows moderate agreement  between GAHS and 
mDF  .     
  
ROC Curve analysis to find out the best cut off point for GAHS to predict 
the 1 month mortality.   
 
Area Under the Curve = 0.972 
The ROC curve analysis suggests that GAHS value ≥ 9.0 is the best cut-
off point to predict the 1 month mortality. 
  
Sensitivity Specificity Analysis for mDF 
 
1 month Mortality 
Total 
Died Survived 
m DF Score 
≥ 32 13 12 25 
< 32 2 23 25 
Total 15 35 50 
 
Parameter Estimate (%) Lower - Upper 95% CIs 
Sensitivity 86.67 62.12, 96.26 
Specificity 65.71 49.15, 79.17 
Positive Predictive Value 52.00 33.50, 69.97 
Negative Predictive Value 92.00 75.03, 97.78 
Diagnostic Accuracy 72.00 58.33, 82.53 
 
 Thus mDF  has a accuracy of 72 % in predicting 1 month mortality.  
Also, out of  25  patients who had discriminant function of  > 32,     13 patients 
died and 12 survived  with a specificity of 65.7 %. Out of  25 patients who had 
score < 32 ,  2 patients died. Also , the positive predictive value is low(52%)   
 
 
   Sensitivity Specificity Analysis for GAHS : 
 
1 month Mortality 
Total 
Died Survived 
GAHS 
Score 
≥ 9 14 2 16 
< 9 1 33 34 
Total 15 35 50 
 
Parameter Estimate (%) Lower - Upper 95% CIs 
Sensitivity 93.33 70.18, 98.81 
Specificity 94.29 81.39, 98.42 
Positive Predictive Value 87.50 63.98, 96.50 
Negative Predictive Value 97.06 85.08, 99.48 
Diagnostic Accuracy 94.00 83.78, 97.94 
 
 Thus GAHS has higher sensitivity,specificity, Positive predictive value,  
negative predictive value and diagnostic accuracy when compared to  mDF .  
   
  
           Among these, the SPECIFICITY, POSITIVE PREDICTIVE VALUE 
and ACCURACY of GAHS  is SIGNIFICANTLY HIGHER compared to mDF 
. Hence GAHS identifies the severity of alcoholic hepatitis accurately compared 
to mDF and this should be used in deciding upon treatment with steroids or 
pentoxifylline.          
Parameter mDF GAHS 
Sensitivity 86.67 93.33 
Specificity 65.71 94.29 
Positive Predictive Value 52.00 87.50 
Negative Predictive Value 92.00 97.06 
Diagnostic Accuracy 72.00 94.00 
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DISCUSSION 
 
 
 
 
 
 
 
 
  DISCUSSION 
 
Alcoholic hepatitis is one of the most prevalent disease. It is increasing 
day by day because of widespread use of alcohol. When severe, the short term 
mortality is very high. This high mortality is mainly due to inflammatory 
processes occurring in acute alcoholic hepatitis. 
 Identification of patients with severe disease is of key significance 
because these patients can be treated with steroids or pentoxifylline and these 
patients need to be monitored for the development of complications like hepatic 
encephalopathy and renal failure. Also these patients need to be followed up 
periodically because alcoholic hepatitis, in the long run is associated with nine 
times increased risk of development of cirrhosis. 
 The severity of disease is identified by mDF  score  ≥ 32. But the 
problem with this score is that it involves only serum bilirubin and Prothrombin 
time. It doesnot include any markers for inflammation or renal involvement.  
The MELD score is cumbersome to calculate and it too doesnot involve 
any marker for inflammation. The GAHS is easy to calculate, involves markers 
for renal involvement and inflammation and is much more accurate than mDF .    
Our study  which was an observational study involved  50 patients with 
alcoholic hepatitis and comparison of actual prognosis with prognosis and 
severity calculated by mDF  and GAHS. 
The observed mortality was 30% . The severity predicted by GAHS had 
an accuracy of 94 % compared to that calculated by mDF which had 72% 
accuracy. Thus it is obvious that GAHS has much better severity prediction 
compared to mDF and this is helpful in treating patients. Also patients with 
GAHS < 9 survived, irrespective of their mDF, even if mDF ≥ 32. This shows 
that if GAHS < 9 , these patients need not be treated with steroids or 
pentoxifylline. 
           There are many studies reported in literature, comparing the various 
prognostic scoring systems. In the E H Forrest et al study,  241 patients were 
studied. The day of admission  GAHS was statistically  significant   than mDF 
in finding out  28 and 84 day mortality. When compared with MELD , the day 1 
GAHS was equally accurate in predicting 28 day mortality and more accurate in 
predicting day 84 outcome. 
In the study conducted by Altamirano-Gomez J et al in mexico, 120 
patients were studied. It was found that in-hospital mortality prediction of 
GAHS and MELD were superior compared to mDF and the prediction of in-
hospital survival after fitting best cut-off points were similar. 
In the study conducted by Sandahl TD et al in Denmark in 274 patients, 
the predicted 28-, 84- and 180 –day mortality of the patients by GAHS, MELD 
and ABIC scores were found to be similar. Rescoring on day seven improved 
the models predictions. 
In the study conducted by H. Lafferty et al, 182 patients  were assessed 
prospectively and compared with historical group which was treated as per 
mDF. At GAHS < 9, the survival rate at day 28 and day 84 were similar. If 
admission  GAHS ≥ 9  who were treated  had survival of 71 % at day 28, 
compared to 41 % of the comparison group with a p-value of 0.0002. at day 84, 
the survival rate was 54 % in the study group and 37 % in the historical group 
with a p-value of 0.008. this shows significant improvement in the outcome in 
patients treated as per GAHS grading of severity.  
  
 In the study by AJ Morris et al, 225 patients with  mDF ≥ 32  ere studied. 
It was found that even if mDF ≥ 32, if  GAHS   <   9, there was no significant 
benefit in treating  these patients with steroids. And patients with GAHS ≥ 9 
had a very high mortality if corticosteroids are not given or they are  
contraindicated. 
In   N Palaniappan’s work  done at Nottingham, 44 patients with biopsy 
proven alcoholic hepatitis were studied. It was found out that  mDF, MELD , 
GAHS and ABIC scores were similar in accuracy in predicting short-term 
mortality. All these scoring systems were poor in predicting long-term 
mortality. The  CP score is  found to be a poor predictor of both short and long 
term  mortality. 
 S Ali studied   82 patients in UK  and  found that mDF , CP and GAHS 
were  of equal accuracy in predicting 28 day mortality. In addition , very high 
PT, raised creatinine, gastro-intestinal bleeding and encephalopathy at the time 
of admission are associated with increased mortality. 
  
 studies  Population  
(number) 
Results  
EH Forrest 241 GAHS more accurate than mDF in 
predicting 28 and 84 day mortality   
Altamirano- Gomez 120 GAHS superior to mDF in predicting 
in-hospital mortality 
Sandahl  274 GAHS, MELD and ABIC scores are 
equal in accuracy 
H Lafferty 182 Improvement in outcome if patients 
are treated with GAHS grading for 
severity. 
AJ Morris 225 At GAHS < 9, no significant benefits 
with coticosteroids. ≥ 9 has poor 
prognosis if not treated 
N Palaniappan 44 mDF , MELD,GAHS and ABIC are 
equal in accuracy. CP score is poor 
in accuracy.  
S . Ali  82 mDF , CP, GAHS are equal in 
accuracy.  
 
These studies show the accuracy of GAHS in comparison with other prognostic 
scoring systems.   
               Winding up, in our study of 50 patients 
 
1]  the GAHS score( 94 %) accurately predicted 1 month mortality when 
compared with mDF (72 % ) . 
2]  The specificity and positive predictive value  of GAHS ( 94.3% and 
87.5%)  were far more superior compared to mDF ( 65.7 %  and  52 % )  
3]  Out of the 25 patients with mDF < 32,  three patients died. Of these three 
patients, two had GAHS ≥ 9 indicating that had GAHS been used to 
identify the severity, these patients could have benefitted with treatment 
of corticosteroids or pentoxifylline. 
4]  One patient who died had both GAHS < 9 and mDF <32. In this case, 
both scores failed to identify the severity 
5] Each factor included in GAHS – age, bilirubin, urea and White cell count, 
with exception of prothrombin time had statistically significant rise in 
those patients who died compared to the survivors, indicating that each 
factor itself gives a clue to the prognosis of the disease. 
 
LIMITATIONS OF THE STUDY: 
1. Very small sample size. 
2. Study group has predominantly males. 
3. Liver biopsy was not done. 
4. Africans and Americans were not included in the study 
5.  The source of error could possibly due to intra-individual variability in 
the laboratory measurement of white cell count, bilirubin, urea  and  PT. 
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SUMMARY AND CONCLUSIONS 
1]  Both  mDF and GAHS predicts one month mortality in alcoholic hepatitis 
2]  GAHS has higher accuracy compared  mDF . out of three patients with 
severe disease which mDF failed to identify, two were identified by 
GAHS  
3] GAHS is easy to calculate. 
4]  Both mDF and GAHS failed to identify severe disease in one patient . 
This could be due to 
- Lack of standardisation in measuring laboratory parameters. 
-  Small sample size 
- Lacunae in the scoring systems 
- Africans and Americans not included in the study 
 
            Extensive research work are under process, which may bring out  
accurate, easily calculable  prognostic scoring systems which could identify 
patients with severe disease, so that the  high short-term mortality associated 
with severe alcoholic hepatitis can be  easily identified and treated and 
unnecessary corticosteroid therapy can be avoided.   Alcoholic hepatitis being  a 
potentially reversible condition , the high short-term mortality   of 40-50 % is 
unacceptable and it has to be prevented. Let us hope we will achieve this in  the 
near future. 
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PROFORMA 
• S.no                                         Date 
• Age 
• IP no 
• Name 
• Sex 
• Unit 
• Phone no. 
• Address 
• occupation 
• Education 
• Income  
 
Presenting complaints:                                                                                                                                                                                                                                                                      
                   jaundice / leg  swelling / altered 
sensorium/fever/abdominal pain 
Past history:  
          DM/HT/PT/SEIZURES/jaundice 
 
Personal history: 
          smoking/alcoholism 
 Examination: 
Pulse-                                    BP- 
RR-   
CVS: 
RS: 
CNS: 
Abdomen: 
Investigations:  
CBC:                      
     Hb- 
     Pcv- 
     TC- 
     DC-      
     RFT: 
     Sugar- 
     Urea- 
     Creatinine- 
    LFT: 
   AST- 
   ALT- 
   S.Bilirubin- 
   s. protein- 
   s. albumin- 
   GGT- 
   SAP- 
   PT/INR-   
USG abdomen:   
 
 
 
 
name age sex WCC Urea total bilirubinSGOT  SGPT PT INR  m DF GAHS 1 month mortality
mani 52 m 4200 22 11.4 245 234 18 1.5 43.6 8 survived
jayakumar 37 m 10100 24 5.4 176 98 16 1.4 23.8 5 survived
nagarathnam 47 m 17400 17.5 17.3 257 212 18 1.5 44.9 9 death
silambarasan 43 m 6300 35 9.6 193 155 15 1.3 23.4 6 survived
raja 39 m 15500 45 7.8 327 261 18 1.5 35.4 9 death
tamizharasan 26 m 4900 28 6.5 246 194 16 1.4 24.9 5 survived
ravi 49 m 27500 46 29.4 279 231 22 1.8 75.4 10 death
kunjithapadham 40 m 12400 52 9.1 293 178 15 1.3 22.9 7 survived
boopathy 39 m 4700 24 5 228 159 22 1.8 51 7 survived
rajarajan 52 m 8700 41 8.7 323 215 17 1.5 31.7 8 death
sripathy 33 m 5600 30 10.6 236 163 16 1.4 29 7 survived
loger 28 m 12100 16 17 168 149 20 1.7 53.8 8 survived
raghu 56 m 17600 54 16 285 127 17 1.5 39 10 death
kalivaradhan 31 m 9300 27 8.9 156 113 17 1.5 31.9 6 survived
balakrishnan 52 m 8200 43 8.6 297 166 19 1.6 40.8 9 survived
rajamoorthy 25  m 7700 19 7.3 254 202 16 1.4 25.7 5 survived
sudakar 34 m 16600 40 15.8 325 176 16 1.4 34.2 9 death
anandan 46 m 12300 42 12.1 269 145 17 1.5 35.1 8 survived
ravikumar 43 m 8100 44 6.1 137 97 15 1.3 19.9 6 survived
krishnasamy 47 m 7500 31 5.9 183 145 17 1.5 28.9 6 survived
maduraiveeran 38 m 12600 38 7.8 281 240 16 1.4 26.2 7 survived
shanmugam 44 m 10500 26 8.3 195 108 17 1.5 31.3 6 survived
kannaih 35 m 18600 36 9.6 190 153 19 1.6 41.8 9 death
mannar 56 m 15300 31 10.9 327 198 16 1.4 29.3 9 death
narayanasamy 34 m 7400 29 9.9 241 119 16 1.4 28.3 6 survived
jagadeesan 48 m 6500 33 6.8 148 114 15 1.3 20.6 6 survived
kuppusamy 43 m 9300 23 12.3 165 104 21 1.7 53.7 7 survived
david 51 m 8300 37 5.7 179 142 17 1.5 28.7 7 survived
subramani 38 m 13800 26 10.1 165 139 19 1.6 42.3 7 survived
irudhayaraj 41 m 16300 37 17.3 217 126 18 1.5 44.9 9 death
pandian 34 m 11600 29 7.4 155 126 15 1.3 21.2 6 survived
rajakannu 42 m 9300 34 8.1 201 103 16 1.4 26.5 7 survived
panchacharam 53 m 8300 44 12.6 176 117 19 1.6 44.8 9 death
ezhil 29 m 19700 34 9.6 194 133 22 1.8 51.6 9 survived
arokiyaraj 31 m 6400 26 5.7 160 104 17 1.5 28.7 5 survived
vinoth 26 m 5700 43 9.2 214 167 15 1.3 23 7 survived
balakottaih 58 m 17800 37 8.1 146 111 16 1.4 26.5 9 death
sureshkumar 47 m 8400 38 10.6 143 84 16 1.4 29 7 survived
palani 39 m 9900 51 8.3 128 103 17 1.5 31.3 7 survived
sugumar 45 m 12800 16 9.7 186 140 16 1.4 28.1 6 survived
fazil 44 m 13200 28 9.3 122 101 21 1.7 50.7 7 survived
arjunan 41 m 18500 35 11.5 139 94 19 1.6 42.7 9 death
abdul kudus 31 m 7900 38 10.5 152 123 19 1.6 42.7 7 survived
diwakar 28 m 4300 27 6.8 141 88 17 1.5 29.8 5 survived
sivakumar 40 m 5600 37 11.3 175 139 15 1.3 24.1 7 survived
munusamy 46 m 16900 43 11.8 206 164 18 1.5 39.4 9 death
lingam 33 m 12600 38 15.4 173 129 23 1.9 66 9 death
srinivasan 37 m 8800 23 6.9 238 154 16 1.4 25.3 5 survived
kumarasamy 62 m 11100 35 8.6 177 132 19 1.6 40.8 10 death
rajendran 27 m 6700 38 10.5 235 146 19 1.6 42.7 7 survived
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
